Skip to content
Home/Companies/Pharma/Horus Pharma
Horus Pharma

Horus Pharma

Pharma·France·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns Horus Pharma?

Horus Pharma is a French Pharma company, currently owned by Eurazeo since 2022.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Eurazeo
Investor
Eurazeo
Nov Sante Actions Non Cotees · 2020 · Healthcare

Key facts

HQFrance
SectorPharma
Websitewww.horus-pharma.com

More from Nov Sante Actions Non Cotees

Other portfolio companies in the same fund.

Proteor
Proteor
Active
MedTechFrance· 2025
Imapole
Imapole
Active
MedTechFrance· 2023
Kinvent
Kinvent
Active
MedTechFrance· 2023
Oncodesign
Oncodesign
Active
BiotechFrance· 2022
Groupe PSIH
Groupe PSIH
Active
HealthTechFrance· 2021
Novair
Novair
Active
MedTechFrance· 2021

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Advantice Health
Advantice Health
Active
TA AssociatesUS
Alcala Farma
Active
Advent InternationalSpain
Alvogen
Alvogen
Active
CVC Capital Partners
Anovo
Anovo
Active
ArdianUS

Questions

Who owns Horus Pharma?

Horus Pharma is currently owned by Eurazeo, through Nov Sante Actions Non Cotees, since 2022.

When did Eurazeo acquire Horus Pharma?

Eurazeo acquired Horus Pharma in 2022.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue